PAUL LING to Viral Matrix Proteins
This is a "connection" page, showing publications PAUL LING has written about Viral Matrix Proteins.
Connection Strength
0.978
-
Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One. 2011; 6(11):e27271.
Score: 0.377
-
The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter. J Virol. 2005 Apr; 79(7):4492-505.
Score: 0.238
-
Multiple Epstein-Barr virus infections in healthy individuals. J Virol. 2003 Jun; 77(11):6546-50.
Score: 0.210
-
EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J Virol. 1994 Sep; 68(9):5375-83.
Score: 0.114
-
EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J Virol. 2004 Nov; 78(22):12694-7.
Score: 0.014
-
Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia. J Infect Dis. 2004 Jul 15; 190(2):396-9.
Score: 0.014
-
Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus. J Virol. 1999 Nov; 73(11):9206-12.
Score: 0.010